Passage Bio, Inc. (PASG)
4.70
-0.34
(-6.75%)
USD |
NASDAQ |
Sep 18, 16:00
4.70
0.00 (0.00%)
After-Hours: 20:00
Passage Bio Price : 4.70 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 4.98 | 5.04 | 4.75 | 5.04 | 3317.00 |
| Sep 16, 2026 | 4.74 | 4.915 | 4.74 | 4.86 | 18038.00 |
| Sep 15, 2026 | 4.83 | 4.845 | 4.70 | 4.77 | 9817.00 |
| Sep 14, 2026 | 4.91 | 5.03 | 4.81 | 4.86 | 30122.00 |
| Sep 11, 2026 | 4.97 | 5.13 | 4.90 | 5.00 | 7890.00 |
| Sep 10, 2026 | 4.99 | 5.215 | 4.90 | 4.985 | 28579.00 |
| Sep 09, 2026 | 4.84 | 5.36 | 4.74 | 4.94 | 197245.0 |
| Sep 08, 2026 | 4.63 | 4.91 | 4.63 | 4.85 | 15225.00 |
| Sep 04, 2026 | 4.63 | 4.874 | 4.63 | 4.65 | 3756.00 |
| Sep 03, 2026 | 4.60 | 4.75 | 4.560 | 4.75 | 8029.00 |
| Sep 02, 2026 | 4.41 | 4.65 | 4.41 | 4.61 | 3437.00 |
| Sep 01, 2026 | 4.425 | 4.445 | 4.40 | 4.44 | 1301.00 |
| Aug 31, 2026 | 4.52 | 4.65 | 4.40 | 4.43 | 16422.00 |
| Aug 28, 2026 | 4.32 | 4.60 | 4.31 | 4.52 | 21893.00 |
| Aug 27, 2026 | 4.46 | 4.53 | 4.31 | 4.33 | 13961.00 |
| Aug 26, 2026 | 4.79 | 4.79 | 4.50 | 4.50 | 6266.00 |
| Aug 25, 2026 | 4.53 | 4.875 | 4.51 | 4.83 | 20720.00 |
| Aug 24, 2026 | 4.37 | 4.66 | 4.30 | 4.51 | 39264.00 |
| Aug 21, 2026 | 4.53 | 4.725 | 4.35 | 4.44 | 36516.00 |
| Aug 20, 2026 | 4.40 | 4.745 | 4.40 | 4.48 | 11335.00 |
| Aug 19, 2026 | 4.66 | 4.97 | 4.50 | 4.51 | 34180.00 |
| Aug 18, 2026 | 4.50 | 4.696 | 4.44 | 4.52 | 8219.00 |
| Aug 17, 2026 | 4.50 | 4.775 | 4.382 | 4.54 | 10536.00 |
| Aug 14, 2026 | 4.52 | 4.67 | 4.42 | 4.59 | 2206.00 |
| Aug 13, 2026 | 4.54 | 4.72 | 4.54 | 4.575 | 4555.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ARS Pharmaceuticals, Inc. | 4.11 |
| ACADIA Pharmaceuticals, Inc. | 27.28 |
| Alnylam Pharmaceuticals, Inc. | 239.57 |
| Anika Therapeutics, Inc. | 20.69 |
| Savara, Inc. | 5.375 |
Price Related Metrics
| PEG Ratio | -0.0086 |
| Price to Book Value | 3.394 |
| Earnings Yield | -240.7% |
| Market Cap | 15.12M |
| PEGY Ratio | -0.0086 |